Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the Form D

The point being missed is that they elected the option to purchase 25,000 shares at 25% above the current share price, instead of a cash settlement.

Why?

.

.

Be well

Share
New Message
Please login to post a reply